Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)
Recruiting now · Early Phase 1
Conditions studied: Radiotracer, Hypertension, Cholesterol
In brief
This study will evaluate the feasibility of using a sub-therapeutic dose of a fluorine-18 analogue of NP-59 (\[18F\]FNP-59) to image the adrenal gland. Some participants are healthy normal subjects but have undergone interventions to manipulate hormones while other participants have known adrenal pathology.
Key facts
- Study ID
- NCT04546126
- Run by
- Benjamin Viglianti
- People needed
- 24
- Starts
- 2021-11-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-12-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Michigan — Ann Arbor, Michigan, United States (enrolling)
- BAMF Health, Inc. — Grand Rapids, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.